Steven Omara
Emergency Medicine · Montgomery, ALNPI 1215972922
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$142
- Lilly USA, LLC$137
- GSK$134
- AbbVie$128
- Portola Pharmaceuticals, LLC$97
- Chiesi USA, Inc.$79
- plus $132 from 5 others
Across 38 payments — averaging $55,843 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$1.5M
- Ortho-clinical Diagnostics, Inc.$600K
- AstraZeneca$2K
- Melinta Therapeutics, LLC$2K
What the payments were for
- Food & beverage$849100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $142 |
| Lilly USA, LLC | 2 | $137 |
| GSK | 6 | $134 |
| AbbVie(2 entities) | 7 | $128 |
| Portola Pharmaceuticals, LLC | 8 | $97 |
| Chiesi USA, Inc. | 1 | $79 |
| Viiv Healthcare Company | 2 | $54 |
| Pfizer | 2 | $31 |
| Novo Nordisk | 1 | $20 |
| AstraZeneca | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$123
- NURTEC ODT$103
How this compares
$849 in reported general payments places this provider in the 90th percentile of 565 emergency medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 45 | $1,102 |
| Valsartan | 11 | $898 |
| Azelastine Hcl | 19 | $537 |
| Diclofenac Sodium | 19 | $488 |
| Cefdinir | 23 | $426 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $424 |
| Amlodipine Besylate | 60 | $405 |
| Losartan Potassium | 42 | $362 |
| Atorvastatin Calcium | 22 | $264 |
| Famotidine | 12 | $251 |
| Levothyroxine Sodium | 11 | $224 |
| Cephalexin | 15 | $171 |
| Amitriptyline Hcl | 11 | $116 |
| Lisinopril | 17 | $65 |
| Azithromycin | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Montgomery
- Brian HassaniMontgomery$4K
- Andrew BurandtMontgomery$813
- Landon ArgoMontgomery$798
- John SullivanMontgomery$591
- Mark MitchellAtmore$309K
- James GalbraithBirmingham$74K
- Lauren WalterBirmingham$64K
- Mark ChristensenBoaz$31K
- Lisa Moreno-WaltonMobile$23K
- Jeremy TownsPell City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.